Login to Your Account



Out with the old, in with the new for generic drug approvals

By Mari Serebrov
Regulatory Editor

Wednesday, January 3, 2018

In the five years since it started collecting generic drug user fees, the FDA has hired 1,000 new employees, amped up its staff training and completely reorganized the way it reviews abbreviated new drug applications (ANDAs).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription